Institute of Biological Chemistry, Academia Sinica, Taipei, 115, Taiwan.
Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, 100, Taiwan.
J Biomed Sci. 2022 May 10;29(1):30. doi: 10.1186/s12929-022-00815-0.
Autophagy plays important roles in cell homeostasis and protein quality control. Long non-coding RNAs (lncRNAs) have been revealed as an emerging class of autophagy regulators, but the majority of them function in regulating the expression of autophagy-related genes. LncRNAs that directly act on the core autophagic proteins remain to be explored.
Immunofluorescence staining and Western blotting were used to evaluate the function of BCRP3 in autophagy and aggrephagy. RNA immunoprecipitation and in vitro RNA-protein binding assay were used to evaluate the interaction of BCRP3 with its target proteins. Phosphatidylinositol 3-phosphate ELISA assay was used to quantify the enzymatic activity of VPS34 complex. qRT-PCR analysis was used to determine BCRP3 expression under stresses, whereas mass spectrometry and Gene Ontology analyses were employed to evaluate the effect of BCRP3 deficiency on proteome changes.
We identified lncRNA BCRP3 as a positive regulator of autophagy. BCRP3 was mainly localized in the cytoplasm and bound VPS34 complex to increase its enzymatic activity. In response to proteotoxicity induced by proteasome inhibition or oxidative stress, BCRP3 was upregulated to promote aggrephagy, thereby facilitating the clearance of ubiquitinated protein aggregates. Proteomics analysis revealed that BCRP3 deficiency under proteotoxicity resulted in a preferential accumulation of proteins acting in growth inhibition, cell death, apoptosis, and Smad signaling. Accordingly, BCRP3 deficiency in proteotoxic cells compromised cell proliferation and survival, which was mediated in part through the upregulation of TGF-β/Smad2 pathway.
Our study identifies BCRP3 as an RNA activator of the VPS34 complex and a key role of BCRP3-mediated aggrephagy in protein quality control and selective degradation of growth and survival inhibitors to maintain cell fitness.
自噬在细胞内稳态和蛋白质质量控制中发挥着重要作用。长链非编码 RNA(lncRNA)已被揭示为一类新兴的自噬调节剂,但它们大多数通过调节自噬相关基因的表达来发挥作用。直接作用于核心自噬蛋白的 lncRNA 仍有待探索。
免疫荧光染色和 Western blot 用于评估 BCRP3 在自噬和聚集体吞噬中的作用。RNA 免疫沉淀和体外 RNA-蛋白质结合测定用于评估 BCRP3 与靶蛋白的相互作用。磷脂酰肌醇 3-磷酸 ELISA 测定用于定量 VPS34 复合物的酶活性。qRT-PCR 分析用于确定应激下 BCRP3 的表达,而质谱和基因本体分析用于评估 BCRP3 缺失对蛋白质组变化的影响。
我们确定 lncRNA BCRP3 是自噬的正调节剂。BCRP3 主要定位于细胞质中,并结合 VPS34 复合物以增加其酶活性。在蛋白酶体抑制或氧化应激诱导的蛋白质毒性下,BCRP3 上调以促进聚集体吞噬,从而促进泛素化蛋白聚集体的清除。蛋白质组学分析显示,在蛋白质毒性下 BCRP3 缺失导致生长抑制、细胞死亡、凋亡和 Smad 信号转导相关蛋白的优先积累。因此,在蛋白质毒性细胞中 BCRP3 缺失会损害细胞增殖和存活,这部分是通过 TGF-β/Smad2 途径的上调介导的。
我们的研究确定 BCRP3 是 VPS34 复合物的 RNA 激活剂,BCRP3 介导的聚集体吞噬在蛋白质质量控制和生长和存活抑制剂的选择性降解中起关键作用,以维持细胞适应性。